These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39180545)

  • 1. Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide.
    Song Y; Huang Q; Pu Q; Ni S; Zhu W; Zhao W; Xu H; Hu K
    Bioconjug Chem; 2024 Sep; 35(9):1380-1390. PubMed ID: 39180545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
    Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.
    Zhang S; Gong Y; Wang H; Li Z; Huang Y; Fu X; Xiang P; Fan T
    J Cell Mol Med; 2021 Apr; 25(8):4062-4072. PubMed ID: 33609076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression.
    Liang J; Xie JX; He J; Li Y; Wei D; Zhou R; Wei G; Liu X; Chen Q; Li D
    Cancer Rep (Hoboken); 2024 Oct; 7(10):e70031. PubMed ID: 39453684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
    Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
    Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide.
    Kan W; Gao L; Chen J; Chen L; Zhang G; Hao B; He M; Chen X; Wang C
    Mol Neurobiol; 2024 Sep; 61(9):7066-7074. PubMed ID: 38368287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide.
    Pinto F; Costa ÂM; Andrade RP; Reis RM
    Neurotherapeutics; 2020 Oct; 17(4):2015-2027. PubMed ID: 32785847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in research and development of temozolomide brain-targeted preparations: a review.
    Yang J; Xu Y; Fu Z; Chen J; Fan W; Wu X
    J Drug Target; 2023 Feb; 31(2):119-133. PubMed ID: 36039767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images.
    Wu S; Calero-Pérez P; Villamañan L; Arias-Ramos N; Pumarola M; Ortega-Martorell S; Julià-Sapé M; Arús C; Candiota AP
    NMR Biomed; 2020 Apr; 33(4):e4229. PubMed ID: 31926117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells-derived exosomes.
    Liu X; Liu L; Wu A; Huang S; Xu Z; Zhang X; Li Z; Li H; Dong J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14599. PubMed ID: 38332576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
    Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
    Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
    [No Abstract]   [Full Text] [Related]  

  • 14. Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.
    Radin DP; Shifman S; Outhwaite IR; Sharma A; Bases R; Seeliger MA; Tsirka SE
    J Pharmacol Exp Ther; 2024 Mar; 389(1):51-60. PubMed ID: 38296645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas.
    Ho KH; Chen PH; Chou CM; Shih CM; Lee YT; Cheng CH; Chen KC
    Neurotherapeutics; 2020 Jul; 17(3):1212-1227. PubMed ID: 31916238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage.
    Huang G; Ouyang M; Xiao K; Zhou H; Zhong Z; Long S; Li Z; Zhang Y; Li L; Xiang S; Ding X
    Life Sci; 2024 Nov; 357():123111. PubMed ID: 39369843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a mouse model bearing orthotopic temozolomide-resistant glioma].
    Shi L; Li H; Gu J; Song C; Li J; Chen L; Zhou Q; Qi S; Lu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):69-74. PubMed ID: 33509755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.